Related Experiment Video
Updated: Oct 21, 2025
06:43
Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
Published on: October 9, 2018
9.8K
In Utero Gene Therapy for Primary Immunodeficiencies
1Department of Obstetrics, Gynecology, and Reproductive Services, University of California, San Francisco, California.
Clinical Obstetrics and Gynecology
|September 5, 2021
Summary
Gene therapy offers a promising treatment for primary immunodeficiencies (PIDs). Fetal gene therapy, or in utero gene therapy, may represent a future direction for improved PID outcomes.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Primary immunodeficiencies (PIDs) are genetic disorders affecting the immune system.
- PIDs are characterized by significant morbidity and mortality.
- Many PIDs have a single-gene etiology, making them suitable for gene therapy.
Purpose of the Study:
- To review current treatments for primary immunodeficiencies.
- To discuss the history and current status of gene therapy for PIDs.
- To explore the potential of fetal gene therapy for treating PIDs.
Main Methods:
- Literature review of PID treatments.
- Review of gene therapy history and applications in PIDs.
- Discussion of in utero gene therapy concepts.
Main Results:
- Gene therapy is a viable treatment for PIDs.
- Early intervention improves treatment outcomes.
- Fetal gene therapy is a potential future treatment strategy.
Conclusions:
- Gene therapy is a key therapeutic strategy for PIDs.
- Fetal gene therapy holds promise for improving outcomes in PIDs.
- Further research into in utero gene therapy is warranted.
Related Concept Videos
00:59Gene Therapy
26.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.2K
01:16In-vitro Mutagenesis
15.4K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.4K
01:25Immunodeficiency Diseases
1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.3K
01:22Development of Immunocompetence
517
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
517